Parian Global Management’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-183,804
Closed -$1.58M 34
2021
Q4
$1.58M Buy
+183,804
New +$1.17M 1.27% 24
2021
Q3
Sell
-84,037
Closed -$558K 60
2021
Q2
$558K Sell
84,037
-126,963
-60% -$800K 0.24% 41
2021
Q1
$2.55M Buy
+211,000
New +$4.19M 1.17% 20

Other funds holding LHDX

Parian Global Management's LHDX Position: Q1 2022 in Review

Parian Global Management sold out of Lucira Health, Inc. Common Stock (LHDX) in Q1 2022, closing a stake of 183,804 shares — an estimated $1.58M sold.

Parian Global Management first reported a position in LHDX in Q1 2021 and held it in 3 quarters. The position peaked at $2.55M in Q1 2021. 40 funds tracked by Wall St. Rank hold LHDX as of Q1 2022.

  • Parian Global Management reported no remaining Lucira Health, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Parian Global Management sold 183,804 Lucira Health, Inc. Common Stock shares in Q1 2022, an estimated $1.58M.
  • Parian Global Management first reported a position in Lucira Health, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • Parian Global Management's Lucira Health, Inc. Common Stock position peaked at $2.55M in Q1 2021.
  • 40 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q1 2022.

Based on Parian Global Management's 13F filing for Q1 2022, filed 16 May 2022.